HSBC Holdings’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
MA
BFM
CCM
PLC
HSBC Holdings's MXCT Position: Q2 2026 in Review
HSBC Holdings reduced its MaxCyte (MXCT) stake by 38% in Q2 2026, selling an estimated $94K and leaving 155,801 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #2717.
HSBC Holdings first reported a position in MXCT in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.25M in Q3 2021. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.
- HSBC Holdings held 155,801 shares of MaxCyte worth $189K as of Q2 2026.
- HSBC Holdings sold 94,371 MaxCyte shares in Q2 2026, an estimated $94K.
- MaxCyte made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2717 holding.
- HSBC Holdings first reported a position in MaxCyte in Q3 2021 and has held it in 20 quarters since.
- HSBC Holdings's MaxCyte position peaked at $1.25M in Q3 2021.
- 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.
Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.